Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of the DPPIV Inhibitor Sitagliptin in Cystic Fibrosis-related Diabetes

NCT01257464 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT01257464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of the DPPIV Inhibitor Sitagliptin in Cystic Fibrosis-related Diabetes
Lead sponsor
University of British Columbia
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2010
Completion date
June 30, 2012
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis